Advertisement
Clinical studies| Volume 108, ISSUE 7, P554-560, May 2000

Autoantibodies against platelet glycoproteins in critically ill patients with thrombocytopenia

      Abstract

      PURPOSE: The aim of the study was to investigate immunologic causes of thrombocytopenia in critically ill patients, especially causes that were related to platelet-associated IgG antibodies.
      SUBJECTS AND METHODS: All patients admitted to two intensive care units between May 1 and October 30, 1997, who developed thrombocytopenia (less than 100 × 109 platelets/L) were studied prospectively. We measured platelet-associated IgG with a radioimmunoassay using I125-labeled polyclonal antihuman IgG. Characterization of platelet-associated IgG was assessed with a monoclonal antibody immobilization of platelet antigen. Circulating immune complexes were also assayed.
      RESULTS: Of the 61 patients with thrombocytopenia, elevated platelet-associated IgG was found in 18 (30%). Associated antiplatelet autoantibodies (glycoprotein IIb/IIIa) were detected in 4 patients, circulating autoantibodies (glycoprotein Ib/IX) were detected in sera from 2 patients, and circulating immune complexes were detected in 3 patients. The nature of the platelet-associated IgG could not be determined in 10 patients. Elevated platelet-associated IgG was associated with sepsis and previous cardiopulmonary bypass. Thrombocytopenic patients with elevated platelet-associated IgG had a lower nadir platelet count (58 ± 27 × 109/L vs 74 ± 24 × 109/L, P = 0.03).
      CONCLUSION: Elevated platelet-associated IgG, some of which are platelet autoantibodies, is frequent in thrombocytopenic patients with sepsis or after cardiopulmonary bypass.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stéphan F
        • Hollande J
        • Richard O
        • et al.
        Thrombocytopenia in a surgical intensive care unit.
        Chest. 1999; 115: 1363-1370
        • Bogdonoff D.L
        • Williams M.E
        • Stone D.J
        Thrombocytopenia in the critically ill patient.
        J Crit Care. 1990; 5: 186-205
        • Wilson J.J
        • Neame P.B
        • Kelton J.G
        Infection-induced thrombocytopenia.
        Semin Thromb Hemostas. 1982; 8: 217-233
        • Stéphan F
        • Thiolière B
        • Verdy E
        • Tulliez M
        Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock.
        Clin Infect Dis. 1997; 25: 1159-1164
        • François B
        • Trimoreau F
        • Vignon P
        • et al.
        Thrombocytopenia in the sepsis syndrome.
        Am J Med. 1997; 103: 114-120
        • Kelton J.G
        • Neame P.B
        • Gauldie J
        • Hirsh J
        Elevated platelet-associated IgG in the thrombocytopenia of septicemia.
        NEJM. 1979; 300: 760-764
        • Poskitt T.R
        • Poskitt P.K.F
        Thrombocytopenia of sepsis. The role of circulating IgG-containing immune complexes.
        Arch Intern Med. 1985; 145: 891-894
        • Burns E.R
        • Lee V
        • Rubinstein A
        Treatment of septic thrombocytopenia with immune globulin.
        J Clin Immunol. 1991; 11: 363-368
        • George J.N
        Platelet immunoglobulin G.
        Blood. 1990; 76: 859-870
        • Warmer M
        • Kelton J.G
        Laboratory investigation of immune thrombocytopenia.
        J Clin Pathol. 1997; 50: 5-12
        • Van der Lelie J
        • van der Plas-Van Dalen C.M
        • von dem Borne AEGKr
        Platelet autoantibodies in septicemia.
        Br J Haemat. 1984; 58: 755-760
        • Kauffmann R.H
        • Thompson J
        • Valentijn R.M
        • et al.
        The clinical implications and the pathogenetic significance of circulating immune complexes in infective endocarditis.
        Am J Med. 1981; 71: 17-25
        • Kiefel V
        • Santoso S
        • Weisheit M
        • Müller-Eckhardt C
        Monoclonal antibody-specific immobilization of platelet antigens (MAIPA).
        Blood. 1987; 70: 1722-1726
        • Berchtold P
        • Müller D
        • Beardsley D
        • et al.
        International study to compare antigen-specific methods used for the measurement of antiplatelet autoantibodies.
        Br J Hematol. 1997; 96: 477-483
        • Berchtold P
        • Wenger M
        Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura.
        Blood. 1993; 5: 1246-1250
        • Kiefel V
        • Freitag E
        • Kroll H
        • et al.
        Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins IIb/IIIa, and Ib/IX in patients with thrombocytopenia.
        Ann Hematol. 1996; 72: 280-285
        • Brighton T.A
        • Evans S
        • Castaldi P.A
        • et al.
        Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias.
        Blood. 1996; 88: 194-201
        • Debré M
        • Bonnet M.-C
        • Fridman W.-H
        • et al.
        Infusion of Fcg fragments for treatment of children with acute immune thrombocytopenic purpura.
        Lancet. 1993; 342: 945-949
        • McCabe W.R
        • Jackson G.G
        Gram-negative bacteria I. Etiology and ecology.
        Arch Intern Med. 1962; 110: 847-864
        • Knaus W.A
        • Draper E.A
        • Wagner D.P
        • Zimmerman J.E
        APACHE II.
        Crit Care Med. 1985; 18: 818-829
        • Fagon J.-Y
        • Chastre J
        • Novara A
        • et al.
        Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection.
        Intens Care Med. 1993; 19: 137-144
        • Hebbar M
        • Kaplan C
        • Caulier M.T
        • et al.
        Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy.
        Br J Haematol. 1996; 94: 112-115
      1. Practice guidelines for blood component therapy. A report by the American Society of Anesthesiologists task force on blood component therapy. Anesthesiology. 1996; 84:732–747.

        • American College of Chest Physicians/Society of Critical Care Medicine Consensus Committee
        Definitions for sepsis and organ failures and guidelines for the use of innovative therapies in sepsis.
        Crit Care Med. 1992; 20: 864-874
        • George J.N
        • Raskob G.E
        • Rizvi Shah S
        • et al.
        Drug-induced thrombocytopenia.
        a systematic review of published case reports. Ann Intern Med. 1998; 129: 886-890
        • Panzer S
        • Szamait S
        • Bödeker R.-H
        • et al.
        Platelet-associated immunoglobulins IgG, IgM, IgA, and complement C3 in immune, and nonimmune thrombocytopenic disorders.
        Am J Hematol. 1986; 23: 89-99
        • McMillan R
        Chronic idiopathic thrombocytopenic purpura.
        NEJM. 1981; 304: 1135-1147
        • Coutinho A
        • Kazatchkine M.D
        • Avrameas S
        Natural autoantibodies.
        Curr Opin Immunol. 1995; 7: 812-818
        • Escher R
        • Müller D
        • Vogel M
        • et al.
        Recombinant human natural autoantibodies against GPIIb/IIIa inhibit binding of autoantibodies from patients with AITP.
        Br J Hematol. 1998; 102: 820-828
        • Salama A
        • Mueller-Eckhardt C
        Immune-mediated blood cell dyscrasias related to drugs.
        Sem Hematol. 1992; 29: 54-63
        • Waters A.H
        Autoimmune thrombocytopenia.
        Sem Hematol. 1992; 29: 18-25
        • George J.N
        • Pickett E.B
        • Saucerman S
        • et al.
        Platelet surface glycoproteins. Studies on resting and activated platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.
        J Clin Invest. 1986; 78: 340-348
        • Kelton J.G
        • Steeves K
        The amount of platelet-bound albumin parallels the amount of IgG on washed platelets from patients with immune thrombocytopenia.
        Blood. 1983; 62: 924-927
      2. Campbell FW, Edmunds LH Jr. Platelet function and cardiopulmonary bypass. In: Gravlee GP, Davis RF, Utley JR, eds. Cardiopulmonary Bypass. Principles and Practice. Baltimore: Williams & Wilkins, 1993:407–435.